Treatment of Hematological Malignancies With Nonmyeloablative, HLA-haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Best Practice and Research in Clinical Haematology - United Kingdom
doi 10.1016/j.beha.2011.05.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search